Reprogramming murine telomerase rapidly inhibits the growth of mouse cancer cells in vitro and in vivo.
about
Telomere and Telomerase Therapeutics in CancerCirculating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: a phase III metastatic castration resistant prostate cancer trial.Cancer cells acquire a drug resistant, highly tumorigenic, cancer stem-like phenotype through modulation of the PI3K/Akt/β-catenin/CBP pathway.Cancer cells cyclically lose and regain drug-resistant highly tumorigenic features characteristic of a cancer stem-like phenotype.Prostate tumor cells with cancer progenitor properties have high telomerase activity and are rapidly killed by telomerase interference.A cancer detection platform which measures telomerase activity from live circulating tumor cells captured on a microfilter.
P2860
Reprogramming murine telomerase rapidly inhibits the growth of mouse cancer cells in vitro and in vivo.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Reprogramming murine telomeras ...... er cells in vitro and in vivo.
@ast
Reprogramming murine telomeras ...... er cells in vitro and in vivo.
@en
type
label
Reprogramming murine telomeras ...... er cells in vitro and in vivo.
@ast
Reprogramming murine telomeras ...... er cells in vitro and in vivo.
@en
prefLabel
Reprogramming murine telomeras ...... er cells in vitro and in vivo.
@ast
Reprogramming murine telomeras ...... er cells in vitro and in vivo.
@en
P2093
P2860
P1476
Reprogramming murine telomeras ...... er cells in vitro and in vivo.
@en
P2093
Amir Goldkorn
Chun-Peng Liao
Yucheng Xu
P2860
P304
P356
10.1158/1535-7163.MCT-09-0682
P577
2010-02-02T00:00:00Z